DALCOR PHARMA UK LTD
Company number 09429551 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£412,008,591
Balance sheet as at 2024-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2015-02-09
- Employees
- 3 (2024 accounts)
- Registered office
- Q3, The Square, Randalls Way, Leatherhead, England, KT22 7TW
- Postcode
- KT22 7TW
- Capital
- 1 USD
- Accounts category
- Total Exemption Full
- Charges
- 0 outstanding
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-02-09
- Next due by
- 2027-02-23
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 4 current · 9 resigned
Contact details
- Website
- dalcorpharma.com
DalCor is developing dalcetrapib, a precision pharmacogenetic medicine for patients with a heart attack to reduce the risk of recurrent myocardial infarction.
Previous company names
| Name | Date changed |
|---|---|
| HELIUM MIRACLE 154 LIMITED | 2015-02-16 |
Previous registered addresses 2
| Address | Changed on |
|---|---|
| 123 WELLINGTON ROAD SOUTH, STOCKPORT, CHESHIRE, SK1 3TH, UNITED KINGDOM | 2019-08-12 |
| 3RD FLOOR 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE, WA14 2DT, UNITED KINGDOM | 2016-09-15 |
Among its peers
Among the oldest 25%
of 33 similar companies in KT, trading since 2015
Competitors Epsom
-
1. BIOPTIX LTD
This company ranks 23 among research and experimental development on biotechnology in Epsom.
The class of 2015
39%
of the 363 companies in this sector incorporated in 2015 are still active today; 58% have since been dissolved.
A fact about the year, not a forecast for this company.